Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health has reported Current Deferred Revenue for 8 years, with the latest figure at $70.5 million in Q2 2026.

• Quarterly Current Deferred Revenue fell 17.46% year-over-year to $70.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $70.5 million (down 17.46% YoY) and the FY2025 annual result came in at $71.4 million, down 19.8% from the prior year.
• Current Deferred Revenue eased to $70.5 million in Q2 2026 per TDOC's latest filing, from $76.1 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $121.6 million in Q2 2023 and troughed at $70.5 million in Q2 2026.
• A 5-year average of $98.0 million and a median of $103.0 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 50.55% in 2022, then fell 27.58% in 2025.
• Over 5 years, Current Deferred Revenue stood at $113.8 million in 2022, then retreated by 3.96% to $109.3 million in 2023, then retreated by 18.48% to $89.1 million in 2024, then fell by 19.8% to $71.4 million in 2025, then declined by 1.35% to $70.5 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $70.5 million, $76.1 million, and $71.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.